The Priority Review

Tag

MASLD

1 story

  1. Clinical trials

    Boehringer Ingelheim registers Phase 3b trial of Survodutide in MASLD

    This study was first posted on ClinicalTrials.gov on September 30, 2026. The trial plans to enroll 600 participants and planned start date is October 23, 2026.